Citilab Healthcare (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 31-07-2024
- Paid Up Capital ₹ 1.48 Cr
as on 31-07-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -27.17%
(FY 2023)
- Profit -72.24%
(FY 2023)
- Ebitda -70.13%
(FY 2023)
- Net Worth 9.41%
(FY 2023)
- Total Assets 7.72%
(FY 2023)
About Citilab Healthcare (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parveez Ahmed, Syed Ahmed, Tanveer Mohamed, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100KA2015PTC082314
- Company No.
082314
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Citilab Healthcare (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Nayaz  | Director | 17-Aug-2015 | Current |
| Parveez Ahmed | Director | 17-Aug-2015 | Current |
| Syed Ahmed | Director | 07-Oct-2017 | Current |
| Tanveer Mohamed | Director | 07-Oct-2017 | Current |
Financial Performance of Citilab Healthcare (India).
Citilab Healthcare (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.17% decrease. The company also saw a substantial fall in profitability, with a 72.24% decrease in profit. The company's net worth moved up by a moderate rise of 9.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Citilab Healthcare (India)?
In 2023, Citilab Healthcare (India) had a promoter holding of 12.82% and a public holding of 87.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primecare Pharma Private LimitedActive 6 years 10 monthsParveez Ahmed and Mohamed Nayaz are mutual person
Primecare Trading & Consulting LlpActive 4 years 2 monthsParveez Ahmed and Mohamed Nayaz are mutual person
- Primecare Medical Services And Multispeciality Clinics (India) Private LimitedActive 12 years 2 months
Parveez Ahmed, Syed Ahmed and 2 more are mutual person
- Primecare Enterprises Private LimitedActive 6 years 11 months
Parveez Ahmed and Mohamed Nayaz are mutual person
Pharmolife Biotechnologies Private LimitedActive 11 months 14 daysParveez Ahmed and Mohamed Nayaz are mutual person
- Gloaid Pharma Private LimitedActive 9 months 2 days
Parveez Ahmed and Mohamed Nayaz are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Citilab Healthcare (India)?
Unlock and access historical data on people associated with Citilab Healthcare (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citilab Healthcare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citilab Healthcare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
